Hospital General Teofilo Davila
In 2026, Hospital General Teofilo Davila appears as a buyer in 22 records from SERCOP open contracting releases, which amount to 21 unique processes. The most frequent supplier, Representaciones Pedro Araneda Ferrer e Hijos CIA. LTDA., accounts for 16.7% of the records shared with suppliers. In Sep 2026, the number of processes is 200% higher than in Aug 2026. Monetary totals are omitted because the source repeats lifecycle rows for each process.
Create and download this entity’s chart- Source records
- 22
- Sources
- 1
Observed volume
21 processes
22 source rows in SERCOP open contracting releases.
Latest activity
Sep 2026
3 records in the period.
Latest comparable change
+2 processes
Aug 2026 → Sep 2026 (+200%)
Most frequent supplier
3 shared records · 16.7% of relationships.
History
Hospital General Teofilo Davila: processes by period
Mar 2026–Sep 2026
Relationships
Top counterparties in the records
Ranked by shared record count, without adding different currencies.
Relationship concentration
Reliance on leading suppliers
Each currency is calculated separately. A high share may reflect specialization, scale, or source coverage and is not by itself evidence of misconduct.
Recent activity
Latest published records
Ordered by the most relevant award, publication, or event date in each source. An identical event published by multiple lifecycle sources is shown once and retains every source in the first column. This does not claim the activity happened today.
| Source | Award date | Publication date | Title | Supplier | Status | Amount | Currency |
|---|---|---|---|---|---|---|---|
| SERCOP open contracting releases | Sep 03, 2026 | Sep 23, 2026 | SIE-HGTD-2026-020-48853 | Representaciones Pedro Araneda Ferrer e Hijos CIA. LTDA. | active | $65,780 | USD |
| SERCOP open contracting releases | Sep 02, 2026 | Sep 17, 2026 | SIE-HGTD-2026-019-48853 | Nefrocontrol S.A. | active | $238,820 | USD |
| SERCOP open contracting releases | Aug 05, 2026 | Aug 18, 2026 | SIE-HGTD-2026-018-48853 | Ecuaquimica Ecuatoriana de Productos Quimicos C.A. | active | $21,840 | USD |
| SERCOP open contracting releases | Jul 27, 2026 | Aug 07, 2026 | SIE-HGTD-2026-017-48853 | Serrano Marquez Elsa Mercedes | active | $162,227.11 | USD |
| SERCOP open contracting releases | Jul 16, 2026 | Jul 27, 2026 | RE-PU-HGTD-2026-002-48853 | Coheco S.A. | active | $38,193.28 | USD |
| SERCOP open contracting releases | Jul 16, 2026 | Jul 27, 2026 | RE-PU-HGTD-2026-002-48853 | Coheco S.A. | active | $12,750.12 | USD |
| SERCOP open contracting releases | Jul 14, 2026 | Jul 30, 2026 | SIE-HGTD-2026-016-48853 | Moonpharma Cia.ltda. | active | $28,332 | USD |
| SERCOP open contracting releases | Jul 08, 2026 | Jul 22, 2026 | SIE-HGTD-2026-008-48853 | Coflent CIA. LTDA | active | $11,700 | USD |
| SERCOP open contracting releases | Jul 07, 2026 | Jul 28, 2026 | SIE-HGTD-2026-015-48853 | Bitrodiagnostico CIA. LTDA. | active | $27,648.95 | USD |
| SERCOP open contracting releases | Jul 04, 2026 | Jul 28, 2026 | SIE-HGTD-2026-009-48853 | Insutrauma S.A.S. | active | $56,200 | USD |
| SERCOP open contracting releases | Jul 01, 2026 | Jul 09, 2026 | SIE-HGTD-2026-013-48853 | Gallardo Pazmiño Marvin Wilfrido | complete | $41,345.33 | USD |
| SERCOP open contracting releases | Jun 23, 2026 | Jul 14, 2026 | SIE-HGTD-2026-012-48853 | Representaciones Pedro Araneda Ferrer e Hijos CIA. LTDA. | active | $80,703.65 | USD |
Entity monitoring
Monitor Hospital General Teofilo Davila
Get an email when linked records change. Alerts make clear that a change may be new activity, broader coverage, or a source correction.
Coverage and provenance
Sources contributing to this profile
Procurement histories collapse repeated lifecycle rows when process identifiers are complete and mark incomplete identifiers as approximate.
Headline monetary rollups are omitted because the primary history cannot deduplicate lifecycle snapshots to award-line values safely; source-row counts remain available in provenance.
This profile consolidates source keys within one country and role only through exact identifiers or an unambiguous normalized legal name. Currencies and unit scales remain separate; similar names are not assumed to be the same organization.